4//SEC Filing
TERRERI PETER R 4
Accession 0001723128-19-000067
CIK 0001723128other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 5:46 PM ET
Size
11.3 KB
Accession
0001723128-19-000067
Insider Transaction Report
Form 4
TERRERI PETER R
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2019-05-08+6,107→ 76,299 total - Award
Restricted Stock Units
2019-05-06+6,459→ 6,459 total→ Class A Common Stock (6,459 underlying) - Award
Stock Option
2019-05-06+28,044→ 28,044 totalExercise: $14.05Exp: 2029-05-06→ Class A Common Stock (28,044 underlying) - Exercise/Conversion
Restricted Stock Units
2019-05-08−6,107→ 0 total→ Class A Common Stock (6,107 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
- [F3]Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Restricted stock units have no expiration date.
- [F4]On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001238456
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 5:46 PM ET
- Size
- 11.3 KB